Sclerosing rhabdomyosarcoma in childhood: Case report and review of the literature

Pediatric and Developmental Pathology

Volumn 7, Issue 4, 2004, Pages 391-396

  Vadgama, Bhumita ^a   Sebire, Neil James ^a   Malone, Marian ^a   Ramsay, Alan Drummond ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Hyaline; MyoD 1; Pediatric; Rhabdomyosarcoma; Sclerosing

Indexed keywords

ACTIN; ANTINEOPLASTIC AGENT; HYALIN; MYOD1 PROTEIN; MYOGENIN; SMOOTH MUSCLE ACTIN; UNCLASSIFIED DRUG;

CANCER CHEMOTHERAPY; CASE REPORT; CHILDHOOD DISEASE; CLINICAL FEATURE; DIAGNOSTIC IMAGING; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHABDOMYOSARCOMA; SCLEROSING RHABDOMYOSARCOMA; STAINING; SYMPTOM; TUMOR BIOPSY;

EID: 4344587477     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10024-003-9453-5     Document Type: Review

References (15)

1. Parham DM. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 2001;14:506-514.
2. Mentzel T, Katenkamp D. Sclerosing, pseudovascular rhabdomyosarcoma in adults; clinicopathological and immunohistochemical analysis of three cases. Virchows Arch 2000;436:305-311.
3. Folpe AL, McKenney JK, Bridge JA, Weiss SW. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol 2002;26:1175-1183.
4. McDowell HP. Update on childhood rhabdomyosarcoma. Arch Dis Child 2003;88:354-357.
5. Qualman SJ, Coffin CM, Newton WA, et al. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol 1998;1:550-561.
6. Newton WA Jr, Gehan EA, Webber BL, et al. Classification of rhabdomyosarcoma and related sarcomas: pathologic aspect and proposal for a new classification-an Intergroup Rhabdomyosarcoma Study. Cancer 1995;76:1073-1085.
7. Chiles M, Parham D, Qualman S, et al. Pediatric matrix-rich rhabdomyosarcomas (Abstract). Pediatr Dev Pathol 2002;5:606.
8. Boué D, Parham D, Teot L, Crist WM, Qualman SJ. Clinicopathologic study of pediatric ectomesenchymomas from Intergroup Rhabdomyosarcoma Study Group III and IV. Pediatr Dev Pathol 2000;3:290-300.
9. Sebire NJ, Malone M. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. J Clin Pathol 2003;56:412-416.
10. Sorensen PHB, Lynch JC, Qualman SJ, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol 2002;20:2672-2679.
11. Parham DM, Barr FG. Embryonal rhabdomyosarcoma In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press, 2002;146-149.
12. Dias P, Chen B, Dilday B, et al. Strong immuostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass. Am J Surg Pathol 2000;156:399-408.
13. Cui S, Hano H, Harada T, Takai S, Masui F, Ushigome S. Evaluation of the new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcoma. Pathol Int 1999;49:62-68.
14. Williams S, Sebire NJ, Ramsay A. Immunohistochemical expression of myogenin and MyoD1 in embryonal, classic alveolar and solid-variant paediatric alveolar rhabdomyosarcoma (Abstract). J Pathol 2002;198:25A.
15. Barr FG, Qualman SJ, Macris MH, et al., Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. Cancer Res 2002;62:4704-4710.